DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
20.20
+0.64 (3.30%)
At close: Mar 25, 2026, 4:00 PM EDT
20.27
+0.07 (0.37%)
After-hours: Mar 25, 2026, 4:04 PM EDT
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of $554.84 million as of March 25, 2026. Its market cap has increased by 584.14% in one year.
Market Cap
554.84M
Enterprise Value
492.69M
1-Year Change
584.14%
Ranking
Category
Stock Price
$20.20
Market Cap Chart
Since October 22, 2014, DBV Technologies's market cap has decreased from $844.80M to $554.84M, a decrease of -34.32%. That is a compound annual growth rate of -3.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 661.20M | 1.97% |
| Dec 31, 2025 | 648.40M | 987.92% |
| Dec 31, 2024 | 59.60M | -67.52% |
| Dec 29, 2023 | 183.50M | -36.22% |
| Dec 30, 2022 | 287.70M | 63.47% |
| Dec 31, 2021 | 176.00M | -28.57% |
| Dec 31, 2020 | 246.40M | -68.16% |
| Dec 31, 2019 | 773.80M | 141.13% |
| Dec 31, 2018 | 320.90M | -73.54% |
| Dec 29, 2017 | 1.21B | -28.69% |
| Dec 30, 2016 | 1.70B | 22.23% |
| Dec 31, 2015 | 1.39B | 39.07% |
| Dec 31, 2014 | 1.00B | 18.43% |
| Oct 22, 2014 | 844.80M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 575.53M |
| AgomAb Therapeutics NV | 567.54M |
| Tectonic Therapeutic | 564.61M |
| Valneva SE | 556.66M |
| YD Bio | 543.57M |
| Allogene Therapeutics | 538.75M |
| Zevra Therapeutics | 537.21M |
| CorMedix | 510.67M |